Rocket Pharmaceuticals, Inc. (RCKT) NASDAQ

3.35

+0.03(+0.90%)

Updated at August 28 04:00PM

Currency In USD

Valuation

Market Cap1.19B
Enterprise Value1.05B
P/E Ratio-1.54
PEG Ratio-0.34
Price/Sales Ratio41.99
Price/Book Ratio1.12
Enterprise/Revenue41.16
Enterprise/EBITDA-1.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-28.01
Operating Margin-29.14

Management Effectiveness

Return On Assets-0.61
Return On Equity-0.66

Income Statement

Revenue0
Revenue/Share0.08
Gross Profit-9.38M
EBITDA-247.49M
Net Income-258.75M
Diluted EPS-2.73

Balance Sheet

Total Cash271.49M
Total Cash/Share2.45
Total Debt25.2M
Total Debt/Equity0.07
Current Ratio6.39
Book Value Per Share3.19

Price History

52-Week Change-80.71
52-Week High22.01
52-Week Low2.19
Moving Average 50 Days3.03
Moving Average 200 Days7.67

Statistics

Average Volume4.79M
Shares Outstanding107.9M
% Held by Institutions85.48

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateJanuary 05, 2018